Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2024Journal of Clinical MedicineOpen Access

Sodium-Glucose Cotransporter Type 2 Inhibitors Use in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAlicia Guzmán-CarrerasAVAndrea María Vellisca-GonzálezJMJuan Igor Molina-Puente

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guzmán-Carreras et al. (2024) studied this question.

synapsesocial.com/papers/68e64b3cb6db6435875dc238https://doi.org/10.3390/jcm13123485
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Effectiveness of Sodium‐Glucose Cotransporter‐2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction2026 · 1 citations
  2. 2Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Observational Evidence in Geriatric Patients AGING-HF2025 · 15 citations
  3. 3SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials2022 · 30 citations
  4. 4Contemporary Use of Sodium Glucose Co-Transporter 2 Inhibitors in Hospitalized Heart Failure Patients: A “Real-World” Experience2024 · 1 citations
  5. 5Impact of Sodium-Glucose Co-transporter 2 Inhibitors After Discharge in Patients With Heart Failure With Reduced Activities of Daily Living: A Single-Center Retrospective Cohort Study2025